Latest News in the pharma Industry

Top Stories

Sir Andrew Witty to retire from GSK in March 2017

Sir Andrew Witty to retire from GSK in March 2017

17 Mar 2016

The Board will now conduct a formal search for a successor and will consider internal and external candidates for the role.

Read more 
CMA fines pharma companies £45 million

CMA fines pharma companies £45 million

12 Feb 2016

The CMA has fined a number of pharmaceutical companies for anti-competitive conduct and agreements in relation to the supply of paroxetine.

Read more 
Shire to combine with Baxalta, creating the global leader in rare diseases

Shire to combine with Baxalta, creating the global leader in rare diseases

11 Jan 2016

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020.

Read more 
UBM celebrates securing more than 36000 attendees at biggest ever CPhI Worldwide

UBM celebrates securing more than 36000 attendees at biggest ever CPhI Worldwide

7 Jan 2016

World’s largest pharma event sees record exhibitor numbers in Madrid.

Read more 
Pfizer and Allergan to combine

Pfizer and Allergan to combine

23 Nov 2015

As a result of the combination with Allergan and subsequent integration of the two companies, Pfizer now expects to make a decision about a potential separation of the combined company's innovative and established businesses by no later than the end of...

Read more 
BMS to sell its HIV R&D portfolio to ViiV Healthcare

BMS to sell its HIV R&D portfolio to ViiV Healthcare

18 Dec 2015

Transactions are consistent with the evolution of BMS’s strategic focus, including the decision to discontinue its discovery efforts in virology announced in June.

Read more 
Catalent working to re-start production at French facility

Catalent working to re-start production at French facility

16 Nov 2015

Company’s preliminary investigation indicates tha the incidents of out-of-place softgel capsules in several product batches could be related to a deliberate action by one or more individuals.

Read more 
Perrigo shareholders convincingly reject Mylan's tender offer, expressing confidence in Perrigo's long-term strategy

Perrigo shareholders convincingly reject Mylan's tender offer, expressing confidence in Perrigo's long-term strategy

13 Nov 2015

Perrigo will immediately commence its previously announced $2 billion repurchase of Perrigo shares and plans to complete $500 million of the planned repurchase by the end of 2015.

Read more 
Roche to restructure its manufacturing network for small molecules

Roche to restructure its manufacturing network for small molecules

13 Nov 2015

Exiting four sites to optimise capacity utilisation will affect approximately 1,200 positions.

Read more 
Sanofi Pasteur reveals its research on a ”universal” influenza vaccine

Sanofi Pasteur reveals its research on a ”universal” influenza vaccine

9 Nov 2015

The vaccines division of Sanofi presents at the World Vaccine Congress in Spain.

Read more 
Eli Lilly announces expansion of Indianapolis R&D headquarters

Eli Lilly announces expansion of Indianapolis R&D headquarters

2 Nov 2015

New building to feature collaboration-focused workspace.

Read more 
Biogen Q3 2015 revenues increase 11% to $2.8 billion

Biogen Q3 2015 revenues increase 11% to $2.8 billion

22 Oct 2015

Corporate restructuring to result in an 11% workforce reduction.

Read more